SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001082554-20-000012
Filing Date
2020-07-29
Accepted
2020-07-29 06:26:26
Documents
15
Period of Report
2020-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K uthrq22020form8-k.htm   iXBRL 8-K 43608
2 EXHIBIT 99.1 uthrq22020-ex991.htm EX-99.1 235889
  Complete submission text file 0001082554-20-000012.txt   442554

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20200729.xsd EX-101.SCH 4466
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20200729_cal.xml EX-101.CAL 642
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20200729_def.xml EX-101.DEF 1492
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20200729_lab.xml EX-101.LAB 26147
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20200729_pre.xml EX-101.PRE 13598
8 EXTRACTED XBRL INSTANCE DOCUMENT uthrq22020form8-k_htm.xml XML 4460
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 201055655
SIC: 2834 Pharmaceutical Preparations